ONO-7807 / BMS, Ono Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ONO-7807 / BMS, Ono Pharma
NCT03446040: An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread

Hourglass Feb 2019 - Dec 2019 : From P1/2 trial in advanced malignant tumors
Active, not recruiting
1/2
92
Canada, Japan, US, RoW
BMS-986258, Nivolumab, Opdivo, BMS-936558, rHuPH20, Enhanze
Bristol-Myers Squibb
Advanced Cancer
12/24
04/25

Download Options